← Leaderboards
Bryan Choi
Duke University
$684,499
Attributed
$1,337,287
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $652.9K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,337,287 · 2
By mechanism
R01$1,305,576 · 1
F30$31,711 · 1
Top collaborators
- Marcela Valderrama Maus2 shared
Most similar at Duke University
Same institution · by research overlap
- Edward A Miao$16,675,058
- Russell E Ware$48,672,245
- Walter J Koch$36,219,689
- Barton F Haynes$531,570,874
- Yiping Yang$13,692,641
Others in their field
Top investigators on “Aftercare”
- Sharon A Nachman · Johns Hopkins University$78,205,219
- Mary M Horowitz · Medical College Of Wisconsin$74,193,785
- Dan H. Barouch · Fred Hutchinson Cancer Center$60,753,467
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
AftercareAntibodiesAntigensAntigen TargetingBackBindingBiopsyBloodBlood CellsBlood SpecimenBrainBrain NeoplasmsCancer CellCathetersCell KillingCell PhysiologyCell ProliferationCellsCell SecretionCell TypeCerebrospinal FluidChemoresistanceChimeric Antigen ReceptorAdverse Event
Grant awards (3)
Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma$652,851
R01 · FY2025 · CA
Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma$652,725
R01 · FY2024 · CA
Targeting EGFRvIII in Brain Tumors with Bispecific Antibodies$31,711
F30 · FY2013 · CA · contact PI